Report
Nicolas Thorez

ODDO BHF Small & MIDCAP MORNING NEWS - 14/01/2022

De nos échanges avec 253 sociétés, 3 éléments ressortent : i/ un optimisme sur le cycle (demande ferme, peu de stocks, hausses de prix possibles), en dépit d’Omicron, et avec en parallèle, la question du timing de la normalisation de l’économie (S2 2022 ?), ii/ une inflation devenue tangible mais le plus souvent répercutée, iii/ la poursuite du M&A mais plus ciblé. A l’issue du Forum, nous avons effectué près de 61 révisions de nos estimations dont 34 à la hausse seulement, plus de 53...
Underlyings
Abivax SA

ABIVAX is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of novel anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.

Esker SA

ESKER and its subsidiaries are engaged in the design and production of software applications. Co. operates corporate resource access software such as applications and databases for workstations. Co. has three major product groups: Host Access, DeliveryWare and Fax Server. Host Access products allows users to access applications and databases stored on different servers from their own workstations. DeliveryWare responds to the need of companies for automatic management document delivery. Fax Server allows the user to send a fax directly from their workstation.

Theranexus SA

Theranexus SA is a France-based company engaged in the healthcare industry. The Company is a biopharmaceutical entity that develops drug candidates to be used in the treatment of central nervous system (CNS) disorders, including epilepsy, narcolepsy, Parkinson's disease, Alzheimer's disease, neuropathic pain and psychiatric disorders. Its patented technology is aimed at increasing the efficacy of CNS drugs, which are approved and available on the market. The Company's technology is protected, scalable and versatile, and used to generate high value-added proprietary drug candidates for different conditions, while reducing time-to-market and market entry costs and risks in comparison with standard drug development processes. Theranexus SA operates in the domestic market.

Thermador Holding SA

Thermador Groupe. Thermador Groupe SA is a France-based holding company engaged in the distribution of specialized plumbing equipment materials, such as taps, pumps and heating equipment. The Company operates through a number of subsidiaries, including Sferaco, which is engaged in the construction of industrial valves and fittings; Sectoriel, which manufactures motorization for valves; Jetly, which produces domestic pumps and accessories as well as lifting stations; Thermador, which distributes central heating and hot domestic water circuit components; Thermador International, which specializes in exporting the Company's products in Europe; PBtub, which is specialized in the distribution of synthetic material tubes for under-floor heating and distribution of domestic water; Isocel, which constructs boiler and parts; Dipra, which furnishes retail stores in do-it-yourself (DIY) products; Opaline, which is the Company's communications agency, Domac and FGINOX.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Nicolas Thorez

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch